Abstract
ARBO-ZOONET is an international network financed by the European Commission's seventh framework program. The major goal of this initiative is capacity building for the control of emerging viral vector-borne zoonotic diseases, with a clear focus on West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus. To evaluate the status quo of control measures against these viruses, an ARBO-ZOONET meeting was held in Istanbul, Turkey, from 19 to 20 November 2009. The symposium consisted of three themes: (1) vaccines: new and existing ones; (2) antivirals: existing and new developments; and (3) antivector vaccines. In addition, a satellite workshop was held on epidemiology and diagnosis. The meeting brought together foremost international experts on the subjects from both within and without the ARBO-ZOONET consortium. This report highlights selected results from these presentations and major conclusions that emanated from the discussions held.
| Original language | English |
|---|---|
| Pages (from-to) | 709-718 |
| Journal | Vector-Borne and Zoonotic Diseases |
| Volume | 10 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 2010 |
Keywords
- boophilus-microplus
- recombinant vaccine
- immune-responses
- neutralizing antibodies
- antiviral compounds
- ribavirin therapy
- oral ribavirin
- saudi-arabia
- efficacy
- protein